12/23
09:02 am
juns
Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 [Yahoo! Finance]
Low
Report
Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6 [Yahoo! Finance]
12/23
08:00 am
juns
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
Low
Report
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
12/10
02:43 pm
juns
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq [Yahoo! Finance]
Low
Report
$50B+ Longevity Opportunity: Jupiter Neurosciences CEO Christer Rosen & President Alison Silva, Live at Nasdaq [Yahoo! Finance]
12/3
08:00 am
juns
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
Medium
Report
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
12/2
07:07 pm
juns
Jupiter Neurosciences to Participate in NobleCon21 [Yahoo! Finance]
Low
Report
Jupiter Neurosciences to Participate in NobleCon21 [Yahoo! Finance]
11/5
08:30 am
juns
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
High
Report
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
10/27
08:30 am
juns
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
High
Report
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing